Virax Biolabs Group Limited

VRAX

Offer Price Offer Size 3-Year Outlook Volatility 1st Day Turnover
$5.00 1,400,000 Positive High 35.65%

Offering Team

Deal Managers

  • Boustead Securities

Lawyers

  • Loeb & Loeb, LLP

Auditors

  • BF Borgers CPA PC

Pre-IPO Investors

Investors

  • Google Ventures
  • Intel Ventures
  • Patricoff Ventures
  • Kleiner Perkins

Pre-IPO Holdings(%)

  • 30
  • 20
  • 05
  • 18

Deal Highlights

We are a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations of our own, we conduct our substantial operations in the United Kingdom and Hong Kong with operating subsidiaries in Singapore, China and British Virgin Islands and have been operating since 2013. We are a global innovative biotechnology group that primarily engages in sales, distribution and marketing of diagnostics test kits More

Deal Tracker

Investors

Filing

30 Jun, 2022

Offer

21 Jul, 2022

Look Ahead

Lock Up Expiry

21 Jan, 2023

Earning

Nov 1, 2018

IPO Terms

Offer Price $5.00
Offer Size 1M

Market Sentiments

Stock Price